Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
10.1002/2211-5463.12402 103 WanbiaoZ.JingM.ShiZ.TengxiangC.XuekeZ.HaiyangL
Its rare to find someone so knowledgeable yet so approachable
PMID: 27581592 9 Primary carnitine deficiency is a life-long disease
B and her team offer this kind of personalized guidance, helping patients navigate established therapies and rapidly-evolving areas of research
KRT-232 and navitoclax enhance trametinib's anti-Cancer activity of in non-small cell lung cancer patient-derived xenografts with KRAS mutations
however, the non-cell autonomous nature of ALS may indicate potential therapeutic targets
US$ 26.71
US$ 22.42
US$ 22.06
US$ 22.65
US$ 29.06
US$ 20.65
US$ 26.95
US$ 27.76
US$ 28.27
US$ 21.62
US$ 20.78
US$ 27.23
